Navigation Links
Full Agenda Announced for CBI's Commercialization and Market Access Congress (CMAC 2010)
Date:9/30/2010

WOBURN, Mass., Sept. 30 /PRNewswire/ -- The Center for Business Intelligence (CBI) recently announced the full agenda for their life sciences Commercialization and Market Access Congress (CMAC 2010). CBI, a renowned leader in the commercialization arena, has combined four of their most respected events - Product Launch, Product Pricing, Early-Stage Commercialization and Specialty Drug Commercialization - into one comprehensive agenda with extensive coverage of the evolving dynamics impacting market access and commercialization. The Congress takes place December 8-9, 2010 in Orlando, FL.

CMAC 2010 combines both a strategic view of current events impacting commercialization with targeted breakouts and tracks, addressing models for commercialization that respond to the new economic landscape while accounting for the changing relationship between patients, physicians and payers. A keynote panel discussion on "Changes in the Market Access Landscape" will be a highlight at this timely event.

CMAC's speaker faculty includes more than 30 of the country's leading experts from the most innovative biotechnology and medical device companies to the most established pharmaceutical companies including Abbott, AstraZeneca, Bayer HealthCare Pharmaceuticals, Cephalon, Daiichi Sankyo, Endo Pharmaceuticals, Medtronic, Mannkind Corporation, Merck, Pfizer, Schering-Plough, Shire, Talecris Biotherapeutics and many more.  

CMAC 2010 is the industry's only opportunity to participate in an executive-level exchange addressing the overarching product development and launch environment, as well as tactical approaches for pricing, reimbursement, product launch, commercial strategy, branding, managed care and HEOR. For more information on the conference or to view the entire agenda, please visit http://www.cmac2010.com.  

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence (CBI) is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology and medical device industries. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit http://www.cbinet.com.  

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Center for Business Intelligence
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
2. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
3. American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia
4. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
5. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
6. 'Biopolymers Symposium 2010' Agenda Announced
7. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
8. 2008 R&D Innovator of the Year & Scientist of the Year Finalists Announced
9. First Annual Arizona Biotech Day Announced for October 23rd 2008
10. Presenters Announced For MichBio Expos Emerging Business Showcase
11. New Young Investigator Grants for Probiotics Research Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):